Hypertension Clinical Trials

Showing 1421-1440 of 3,009 trials

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

NCT01190007

The primary objective is to investigate the safety of Caduet (2.5 mg/5 mg, 2.5 mg/10 mg, 5 mg/5 mg or 5 mg/10 mg as dose of Amlodipine/Atorvastatin) during 52 weeks treatment period in Japanese patients with both of hypertension and hypercholesterolemia, or with both angina pectoris and hypercholesterolemia.

HypertensionHypercholesterolemiaAngina Pectoris

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.159 participantsStarted Aug 2010

Nagoya, Aichi-ken, Japan • Dazaifu, Fukuoka, Japan • Kitakyushu, Fukuoka, Japan +17 more locations

UNKNOWN

Assessment of Cardiac Function Using Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing (CMR-CPET)

NCT04729777

What problems limit patients' response to exercise? Using exercise cardiac magnetic resonance imaging to assess the heart's response, with simultaneous measurement of respiratory oxygen and carbon dioxide levels to assess the lung and skeletal muscle responses, to identify the rate-limiting factors affecting different types of patient

Pulmonary Hypertension

Royal Free Hospital NHS Foundation Trust100 participantsStarted Mar 2019

London, United Kingdom

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

Assessment of Cardiac Function Using Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing (CMR-CPET)

Related Searches

Amlodipine 10mg Drug Use Investigation

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Amlodipine Diabetic Hypertension Efficacy Response Trial

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension

Effect of Different Antihypertensive Treatment on Serum Uric Acid in Newly Diagnosed Hypertensive Patients

Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control

Post-exercise Hypotension After a Power Training Session in Older Adults With Hypertension

Chronic Sildenafil for Severe Diaphragmatic Hernia

FimasaRtan-basEd BP Targets After Drug SwitcHing

The Prevalence of Pulmonary Hypertension in Patients With COVID-19.

Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients

Optical Nerve Sheath Changes During Head Down Laparoscopy

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058

Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients

The Effect of Sorafenib on Portal Pressure

Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension